Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Individualized rituximab treatment for relapsing neuromyelitis optica: a pediatric case report.
Integrated multi-cohort transcriptional meta-analysis of neurodegenerative diseases.
Flare up reaction during provocation test to glatiramer acetate in a patient with allergy to interferon beta1a.
Aquaporin 4 antibody [NMO Ab] status in patients with severe optic neuritis in India.
Production of IL-27 in multiple sclerosis lesions by astrocytes and myeloid cells: Modulation of local immune responses.
Multi-modal characterization of rapid anterior hippocampal volume increase associated with aerobic exercise.
Transolfactory neuroinvasion by viruses threatens the human brain.
Another promising oral agent for multiple sclerosis.
Two-Photon Fluorescent Imaging of Myelination in the Spinal Cord.
Hypomorphic MGAT5 polymorphisms promote multiple sclerosis cooperatively with MGAT1 and interleukin-2 and 7 receptor variants.
Novel Inhibitors of Protein Arginine Deiminase with Potential Activity in Multiple Sclerosis Animal Model.
An early British case of neuromyelitis optica (1850).
Comparison between Trans-Cranial Electromagnetic Stimulation and Low-Level Laser on Modulation of Trigeminal Neuralgia.
Postural response latencies are related to balance control during standing and walking in patients with multiple sclerosis.
Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency in people with multiple sclerosis: a summary of a Cochrane systematic review.
The effectiveness of aerobic training, cognitive behavioural therapy, and energy conservation management in treating MS-related fatigue: the design of the TREFAMS-ACE programme.
Immune surveillance and response to JC virus infection and PML.
Thrombin mutant W215A/E217A treatment improves neurological outcome and attenuates central nervous system damage in experimental autoimmune encephalomyelitis.
Confounding Parameters in Pre-clinical Assessment of Blood-brain Barrier Permeation: An Overview With Emphasis on Species Differences and Effect of Disease States.
Higher susceptibility to experimental autoimmune encephalomyelitis in Muc1-deficient mice is associated with increased Th1/Th17 responses.
Natalizumab therapy for multiple sclerosis.
A case of classic neuromyelitis optica (Devic's syndrome) triggered by pegylated-interferon α.
Botulinum Toxin Injection Techniques for Management of Adult Spasticity.
Seropositive Neuromyelitis Optica imitating an Intramedullary Cervical Spinal Cord Tumor: Case Report and Brief Review of the Literature.
Preliminary evaluation of variable compliance joystick for people with multiple sclerosis.
Pages
« first
‹ previous
…
427
428
429
430
431
432
433
434
435
…
next ›
last »